JENNIFER MASSLON: Open Payments
NPI 1598309866 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 42 payments from 15 companies in 2025. Trend: 2023 $2,253 · 2024 $1,382 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $282 |
| Janssen Biotech, Inc. | 8 | $232 |
| Sumitomo Pharma America, Inc. | 5 | $116 |
| Dendreon Pharmaceuticals LLC | 4 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $101 |
| ACCORD HEALTHCARE, INC. | 3 | $61 |
| IMMUNITYBIO, INC. | 2 | $51 |
| Endo USA, Inc. | 3 | $45 |
| Teleflex LLC | 1 | $41 |
| 180 Medical, Inc. | 2 | $36 |
Products named: Axonics, ERLEADA, GEMTESA, PROVENGE, Nubeqa, Camcevi, ANKTIVA, XIAFLEX.
Industry payments across NV — which companies pay providers there.
